Anlotinib Capsules in the Treatment for IPF/PF-ILDs
Anlotinib Capsules in the Treatment for IPF/PF-ILDs
Active, not recruiting · NCT05828953 · Registry updated 2026-06-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Anlotinib Capsules in the Treatment for IPF/PF-ILDs | idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Active, not recruiting | Phase 2 | 2026-06-05 | NCT05828953 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 88 |
| First Affiliated Hospital of Wenzhou Medical University | 117 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Wenzhou Medical University | Wenzhou | China | 87 |